Brain microvessel cross‐presentation is a hallmark of experimental cerebral malaria
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Brain microvessel cross‐presentation is a hallmark of experimental cerebral malaria ; volume:5 ; number:7 ; year:2013 ; pages:984-999 ; extent:16
EMBO molecular medicine / European Molecular Biology Organization ; 5, Heft 7 (2013), 984-999 (gesamt 16)
- Urheber
-
Howland, Shanshan W.
Poh, Chek Meng
Gun, Sin Yee
Claser, Carla
Malleret, Benoit
Shastri, Nilabh
Ginhoux, Florent
Grotenbreg, Gijsbert M.
Rénia, Laurent
- DOI
-
10.1002/emmm.201202273
- URN
-
urn:nbn:de:101:1-2023020405531421657325
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Howland, Shanshan W.
- Poh, Chek Meng
- Gun, Sin Yee
- Claser, Carla
- Malleret, Benoit
- Shastri, Nilabh
- Ginhoux, Florent
- Grotenbreg, Gijsbert M.
- Rénia, Laurent
Ähnliche Objekte (12)
Cross‐presentation of malaria antigen by brain microvessels: why CD 8 + T cells are critical for the pathogenesis of experimental cerebral malaria
Neuregulin-1 attenuates mortality associated with experimental cerebral malaria
Uncovering the role of IFNAR1 in experimental cerebral malaria
Experimental Cerebral Malaria Spreads along the Rostral Migratory Stream
Efficacy of intranasal administration of artesunate in experimental cerebral malaria
Differences in antigen presentation between sporozoite and parasitised-erythrocyte infections uncovers divergent mechanisms in the development of experimental cerebral malaria
Differences in antigen presentation between sporozoite and parasitised-erythrocyte infections uncovers divergent mechanisms in the development of experimental cerebral malaria
Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria
Controlled release of artemisone for the treatment of experimental cerebral malaria
Reversal of cerebrovascular constriction in experimental cerebral malaria by L-arginine
KCC1 Activation protects Mice from the Development of Experimental Cerebral Malaria
Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase
Cross‐presentation of malaria antigen by brain microvessels: why CD 8 + T cells are critical for the pathogenesis of experimental cerebral malaria
Neuregulin-1 attenuates mortality associated with experimental cerebral malaria
Uncovering the role of IFNAR1 in experimental cerebral malaria
Experimental Cerebral Malaria Spreads along the Rostral Migratory Stream
Efficacy of intranasal administration of artesunate in experimental cerebral malaria
Differences in antigen presentation between sporozoite and parasitised-erythrocyte infections uncovers divergent mechanisms in the development of experimental cerebral malaria
Differences in antigen presentation between sporozoite and parasitised-erythrocyte infections uncovers divergent mechanisms in the development of experimental cerebral malaria
Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria
Controlled release of artemisone for the treatment of experimental cerebral malaria
Reversal of cerebrovascular constriction in experimental cerebral malaria by L-arginine
KCC1 Activation protects Mice from the Development of Experimental Cerebral Malaria
Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase
Cross‐presentation of malaria antigen by brain microvessels: why CD 8 + T cells are critical for the pathogenesis of experimental cerebral malaria
Neuregulin-1 attenuates mortality associated with experimental cerebral malaria
Uncovering the role of IFNAR1 in experimental cerebral malaria
Experimental Cerebral Malaria Spreads along the Rostral Migratory Stream
Efficacy of intranasal administration of artesunate in experimental cerebral malaria
Differences in antigen presentation between sporozoite and parasitised-erythrocyte infections uncovers divergent mechanisms in the development of experimental cerebral malaria
Differences in antigen presentation between sporozoite and parasitised-erythrocyte infections uncovers divergent mechanisms in the development of experimental cerebral malaria
Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria
Controlled release of artemisone for the treatment of experimental cerebral malaria
Reversal of cerebrovascular constriction in experimental cerebral malaria by L-arginine
KCC1 Activation protects Mice from the Development of Experimental Cerebral Malaria